You’re reading a copy of this week’s edition of the free New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. Sign up to receive a copy...
The Valens Company Reports Record Financial Performance in the Fourth Quarter and Fiscal Year Ended November 30, 2019 with Q4 Adjusted EBITDA(1) of $17.7 Million KELOWNA, BC, Feb. 24,...
Canadian licensed producers experienced their tenth consecutive monthly decline during January, with the Canadian Cannabis LP Index falling 3.1% to 381.71: The index remains substantially below the all-time closing high of 1314.33...
Canadian licensed producers experienced their ninth consecutive monthly decline during December, with the Canadian Cannabis LP Index falling 2.8% to 393.78: The index remains substantially below the all-time closing high of...
Valens Announces Revenue Guidance for Fourth Quarter 2019 and Intention to Commence a Normal Course Issuer Bid Valens announces Q4 2019 revenue guidance of $27 million – $30 million, a near doubling...
After beginning the year with a 57.4% gain in Q1, the Global Cannabis Stock Index moved sharply lower again in November, its eighth consecutive monthly decline, as it lost 12.0% to...
Exclusive Interview with Valens GroWorks CEO and Director Tyler Robson Valens GroWorks (TSXV: VGW) (OTC: VGWCF) is setting itself apart from other cannabis processors by offering a diverse range...
After a 57.4% rebound in Q1, Cannabis stocks, as measured by the Global Cannabis Stock Index, gave up some ground in April, declining 1.5%: The index, which had 64 qualifying...
Partnership supports Organigram’s large-scale extraction and production strategy MONCTON, NB, Jan. 29, 2019 /PRNewswire/ – Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the “Company” or...
